Developer docs
API playgroundTry for free, no card

Search company profiles

The Roskamp Institute

Full company profile

uuid002j7u1

Namestring
The Roskamp Institute
Company typeenum
Private
Founded yearint
2003
Descriptiontext

The Roskamp Institute is a nonprofit biomedical research organization founded in 2003 and headquartered in Sarasota, Florida. It is dedicated to finding cures for neuropsychiatric and neurodegenerative diseases, operating within a headcount band of 101-250 employees. As a nonprofit research entity, the institute's functional role is the conduct of disease-oriented scientific research and drug discovery, targeting conditions such as Alzheimer's disease, Parkinson's disease, and related central nervous system disorders, though specific programs, clinical pipelines, and research foci are not documented in the available data.

The institute's core products and underlying technology are not detailed in the available data. There are no disclosed products, services, patents, certifications, or proprietary platforms in the input. A research organization of this scale and longevity would typically maintain laboratory infrastructure, potentially a clinical research unit, biobank or patient cohort resources, and collaborations with academic medical centers, but none of these are explicitly confirmed. The website (roskampinstitute.org) returned only a loading/verification page during data collection, and no product, technology, or platform information could be retrieved.

The business model is typical of a U.S. nonprofit research institute: revenue is most likely generated through a combination of federal research grants (primarily NIH), foundation grants, individual and corporate philanthropy, and potentially limited royalty or licensing income from any resulting intellectual property. No grant disclosures, donor lists, audited financials, Form 990 filings, pricing models, or GTM mechanics are available in the input data. Customer segments, distribution channels, and value proposition specifics are likewise undocumented, limiting any granular business-model assessment.

Short descriptiontext

The Roskamp Institute is a nonprofit biomedical research organization founded in 2003 in Sarasota, Florida, employing 101-250 staff and dedicated to finding cures for neuropsychiatric and neurodegenerative diseases. It serves the broader patient and scientific community affected by these conditions.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSarasota, United States
HQ citystring
Sarasota
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
neuroscience research, neurodegenerative disease research, neuropsychiatric disease research, biomedical research institute, clinical neuroscience studies
Industry3 codes
1Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryYes
2Neurogenetics & Rare Neurologic Diseases
CodeHLAKAIAOPrimaryNo
3Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryNo
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Neuroscience Research Services
Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Roskamp Institute is a nonprofit research organization that conducts scientific research aimed at discovering cures for neuropsychiatric and neurodegenerative diseases. It carries out biomedical and clinical research activities supported by grants, donations, and institutional collaborations. Specific research programs, clinical trial offerings, or licensing activities are not detailed in the available source content.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Neuropsychiatric and Neurodegenerative Disease Research
CategoryBiomedical Research Services
Description

Scientific research services aimed at finding cures for neuropsychiatric and neurodegenerative diseases, conducted by a dedicated research staff at the institute's Sarasota, Florida facility. Targeted at grant-providing institutions, foundations, and research collaborators supporting disease-cure work.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large nonprofit biomedical research institute conducting neuroscience and drug-discovery research; overlapping mission at a much larger scale.

TypeOthers
Description

Nonprofit focused on funding and advancing drug discovery for Alzheimer's; thematically aligned but primarily a grantmaking/funding entity rather than an in-house research lab.

TypeDirect peer
Description

Independent nonprofit biomedical research organization with a major neurological disease program, comparable as a mission-driven neuroscience research institute.

TypeDirect peer
Description

Independent nonprofit research institute focused on aging and age-related neurodegenerative diseases, closely aligned with Roskamp's research focus and nonprofit model.

TypeBroad incumbent
Description

Large independent neuroscience research institute focused on understanding the brain; overlaps in neuroscience research but at greater scale and breadth.

TypeDirect peer
Description

A dedicated Alzheimer's and neurodegenerative disease research and care institute; directly comparable in its disease-specific neuroscience research mission.

TypeOthers
Description

Disease-specific nonprofit funding neurodegenerative research; shares mission focus but operates as a grantmaking foundation rather than a research institute.

TypeBroad incumbent
Description

Prominent independent nonprofit biomedical research institute with neuroscience programs; comparable model but larger and broader in scientific scope.

TypeDirect peer
Description

Independent biomedical nonprofit research institute conducting neurodegenerative (Parkinson's/Alzheimer's) research, comparable in structure and mission.

TypeDirect peer
Description

Nonprofit biomedical research institute with neuroscience and neurodegenerative disease programs, similar independent research-institute model.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Roskamp Institute

Neuroscience Research Servicesroskampinstitute.org

The Roskamp Institute is a nonprofit biomedical research organization founded in 2003 in Sarasota, Florida, employing 101-250 staff and dedicated to finding cures for neuropsychiatric and neurodegenerative diseases. It serves the broader patient and scientific community affected by these conditions.

What The Roskamp Institute does

The Roskamp Institute is a nonprofit biomedical research organization founded in 2003 and headquartered in Sarasota, Florida. It is dedicated to finding cures for neuropsychiatric and neurodegenerative diseases, operating within a headcount band of 101-250 employees. As a nonprofit research entity, the institute's functional role is the conduct of disease-oriented scientific research and drug discovery, targeting conditions such as Alzheimer's disease, Parkinson's disease, and related central nervous system disorders, though specific programs, clinical pipelines, and research foci are not documented in the available data.

The institute's core products and underlying technology are not detailed in the available data. There are no disclosed products, services, patents, certifications, or proprietary platforms in the input. A research organization of this scale and longevity would typically maintain laboratory infrastructure, potentially a clinical research unit, biobank or patient cohort resources, and collaborations with academic medical centers, but none of these are explicitly confirmed. The website (roskampinstitute.org) returned only a loading/verification page during data collection, and no product, technology, or platform information could be retrieved.

The business model is typical of a U.S. nonprofit research institute: revenue is most likely generated through a combination of federal research grants (primarily NIH), foundation grants, individual and corporate philanthropy, and potentially limited royalty or licensing income from any resulting intellectual property. No grant disclosures, donor lists, audited financials, Form 990 filings, pricing models, or GTM mechanics are available in the input data. Customer segments, distribution channels, and value proposition specifics are likewise undocumented, limiting any granular business-model assessment.

The Roskamp Institute firmographics

Firmographics
Name
The Roskamp Institute
Website
https://roskampinstitute.org
Company type
Private
Founded year
2003
Headcount range
101–250 employees
Short description
The Roskamp Institute is a nonprofit biomedical research organization founded in 2003 in Sarasota, Florida, employing 101-250 staff and dedicated to finding cures for neuropsychiatric and neurodegenerative diseases. It serves the broader patient and scientific community affected by these conditions.
Ownership category
akta.pro rank

The Roskamp Institute industry classification

Industry
Product category
Neuroscience Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
akta.pro secondary industries
Neurogenetics & Rare Neurologic Diseases (HLAKAIAO), Research & Science Grantmaking Foundations (BPAGAKAI)

Keywords

  • Neuroscience research
  • Neurodegenerative disease research
  • Neuropsychiatric disease research
  • Biomedical research institute
  • Clinical neuroscience studies

Where The Roskamp Institute is headquartered

Location

Headquarters

HQ city
Sarasota
HQ country
United States
HQ region
North America

Markets served

The Roskamp Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations

The Roskamp Institute product offering

Product offering

Core offering

The Roskamp Institute is a nonprofit research organization that conducts scientific research aimed at discovering cures for neuropsychiatric and neurodegenerative diseases. It carries out biomedical and clinical research activities supported by grants, donations, and institutional collaborations. Specific research programs, clinical trial offerings, or licensing activities are not detailed in the available source content.

Differentiator

Problem solved

Functional benefit

Products and services

  • Neuropsychiatric and Neurodegenerative Disease Research Scientific research services aimed at finding cures for neuropsychiatric and neurodegenerative diseases, conducted by a dedicated research staff at the institute's Sarasota, Florida facility. Targeted at grant-providing institutions, foundations, and research collaborators supporting disease-cure work.

Companies that use The Roskamp Institute

Customer profile

Ideal customer profiles2 records

The Roskamp Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Roskamp Institute partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

The Roskamp Institute competitors and assessment

Company assessment

Broad incumbents

  • Scripps Research: Large nonprofit biomedical research institute conducting neuroscience and drug-discovery research; overlapping mission at a much larger scale.
  • Allen Institute for Brain Science: Large independent neuroscience research institute focused on understanding the brain; overlaps in neuroscience research but at greater scale and breadth.
  • Salk Institute for Biological Studies: Prominent independent nonprofit biomedical research institute with neuroscience programs; comparable model but larger and broader in scientific scope.

Others

  • Alzheimer's Drug Discovery Foundation: Nonprofit focused on funding and advancing drug discovery for Alzheimer's; thematically aligned but primarily a grantmaking/funding entity rather than an in-house research lab.
  • Cure Alzheimer's Fund: Disease-specific nonprofit funding neurodegenerative research; shares mission focus but operates as a grantmaking foundation rather than a research institute.

Direct peers

  • Gladstone Institutes: Independent nonprofit biomedical research organization with a major neurological disease program, comparable as a mission-driven neuroscience research institute.
  • Buck Institute for Research on Aging: Independent nonprofit research institute focused on aging and age-related neurodegenerative diseases, closely aligned with Roskamp's research focus and nonprofit model.
  • Banner Alzheimer's Institute: A dedicated Alzheimer's and neurodegenerative disease research and care institute; directly comparable in its disease-specific neuroscience research mission.
  • Van Andel Institute: Independent biomedical nonprofit research institute conducting neurodegenerative (Parkinson's/Alzheimer's) research, comparable in structure and mission.
  • Sanford Burnham Prebys: Nonprofit biomedical research institute with neuroscience and neurodegenerative disease programs, similar independent research-institute model.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

The Roskamp Institute social profiles

Digital presence

The Roskamp Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Roskamp Institute leadership team

Management profile

Number of profiles

Profiles1 record

The Roskamp Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Roskamp Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Roskamp Institute

What does The Roskamp Institute do?

The Roskamp Institute is a nonprofit research organization that conducts scientific research aimed at discovering cures for neuropsychiatric and neurodegenerative diseases. It carries out biomedical and clinical research activities supported by grants, donations, and institutional collaborations. Specific research programs, clinical trial offerings, or licensing activities are not detailed in the available source content.

When was The Roskamp Institute founded?

The Roskamp Institute was founded in 2003. It employs 101 to 250 people.

Where is The Roskamp Institute based?

The Roskamp Institute is headquartered in Sarasota, United States, in the North America region.

Who are The Roskamp Institute's main competitors?

Broad incumbents on record are Scripps Research, Allen Institute for Brain Science and Salk Institute for Biological Studies. Others are Alzheimer's Drug Discovery Foundation and Cure Alzheimer's Fund. Direct peers are Gladstone Institutes, Buck Institute for Research on Aging, Banner Alzheimer's Institute, Van Andel Institute and Sanford Burnham Prebys.

Does The Roskamp Institute have an API?

No public API is recorded for The Roskamp Institute.

What industry is The Roskamp Institute in?

The Roskamp Institute's product category is Neuroscience Research Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of HLAKAIAO, Neurogenetics & Rare Neurologic Diseases. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireBiosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology ProgramBiosplice Therapeutics announced a DoD award funding its collaboration with The Roskamp Institute to develop TBI therapies using DYRK inhibitors. The award will fund preclinical development in TBI models, potentially leading to clinical trials. The work may also inform treatment for tauopathies like Alzheimer's and ALS.PR NewswireNew Roskamp Institute Clinical Research Shows Promise of Drug to Slow Early-stage Alzheimer's DiseaseResearchers at the Roskamp Institute published new clinical trial data showing that Nilvadipine, a hypertension drug, reduced cognitive decline by nearly 50 percent in patients with very early stage Alzheimer's disease over 18 months compared to placebo. The study, conducted across nine European countries, found that the drug was not beneficial and may have worsened outcomes in patients who began treatment at later stages of the disease. The institute has received NIH funding to develop second-generation drugs that could replicate Nilvadipine's beneficial effects without unwanted side effects.PR NewswireJust a Few Tickets Remain For Roskamp Institute's Grey Matters Symposium on Alzheimer's Disease ResearchThe Roskamp Institute announced that its second annual Grey Matters symposium on Alzheimer's Disease Research is nearly sold out, with CEO Fiona Crawford expressing enthusiasm about the strong community support. The event will feature presentations on brain health topics including potential treatments, prevention strategies, and clinical research updates, with all funds raised supporting medical research at the Institute. Founded in Sarasota, Florida in 2003, the Institute has emerged as a leading not-for-profit research organization with discoveries for Alzheimer's and other neurological disorders, supported by agencies including the National Institutes of Health and the U.S. Department of Veterans Administration.GlobeNewswireAnavex Agreement With The Roskamp Institute to Advance the Clinical Development of ANAVEX PLUSAnavex Life Sciences announced an agreement with The Roskamp Institute to advance clinical development of ANAVEX PLUS, a combination of ANAVEX 2-73 and donepezil for Alzheimer's disease. Preclinical data showed up to 80% greater memory improvement in animal models versus donepezil alone, and a patent application was filed. The company expects the patent to extend at least until 2033.Business InsiderStar Scientific Shares Spike As It Stumbles Onto A Potential Alzheimer's CureStar Scientific's shares rose over 46% in five days after it reported a nicotine compound, antabine, that reduces amyloid protein, a potential Alzheimer's treatment. The stock, trading at $2.37, is its highest in 11 months, though the drug still faces a three-month Roskamp Institute study and FDA approval.